No matter how much health data you collect, it’s only valuable if it’s inclusive of entire affected populations. Bias and care access barriers often cause data gaps that leave healthcare professionals with an incomplete picture of who they need to serve, impeding their ability to address disparities and diminishing the quality of real-world data we depend on for drug development, care delivery, and AI.
How can we achieve complete and representative data to better serve all populations? On this episode of Diagnosing Healthtech, we hear from two accomplished experts: Susan C. Winckler, RPh, Esq and Carla Rodriguez-Watson, PhD, MPH, who currently serve as CEO and Director of Research (respectively) of the Reagan-Udall Foundation for the FDA.
Topics from this episode include:
- The importance of Social Determinants of Health (SDOH) when screening for care delivery and clinical trials
- How to reduce barriers to assessing SDOH through development of new treatments and novel therapeutics
- How healthcare leaders can partner with communities to collect the best data and advance access to quality care.
Subscribe for DHT email updates
Related Posts
Rethinking chronic pain management with Jennie Shulkin on Diagnosing Healthtech
https://www.youtube.com/watch?v=mimCIJFgN48 According to the U.S. Pain Foundation, more than 50 million Americans live with chronic pain, yet traditional…
